Phenobarbital is a long-acting barbiturate that some hospitals use to treat moderate to severe alcohol withdrawal, especially when symptoms are escalating or benzodiazepines are not a good fit. It is not a drug to take on your own. Because of its narrow safety margin, it belongs in settings where trained clinicians can dose it and watch you closely. This guide explains what it does, how it compares with Ativan-type drugs, what the risks are, and how to decide where to get care.
TL;DR
- Phenobarbital calms the overexcited nervous system of alcohol withdrawal and stays in the body for days, which helps prevent seizures and delirium tremens.
- Benzodiazepines remain the usual first-line choice. Phenobarbital is an alternative for people at risk of complicated withdrawal or in severe withdrawal, when extensive monitoring is available.
- The main danger is over-sedation and slowed breathing, which is why guidelines limit certain forms of it to highly supervised settings.
- Seizures, hallucinations or confusion during withdrawal are emergencies. Call 911 or go to an emergency department.
- Never combine alcohol, sedatives or leftover prescriptions to "self-manage" withdrawal.
Table of Contents
- What phenobarbital is and why it is used in withdrawal
- Phenobarbital vs. Ativan and other benzodiazepines
- How clinicians dose and monitor it
- Risks, side effects and interactions
- Who may be considered for phenobarbital
- When withdrawal is an emergency
- Perspective
- Medically supervised detox in Van Nuys
- How to prepare for a supervised withdrawal
- What families should know
- FAQ
- Sources
What phenobarbital is and why it is used in withdrawal
Phenobarbital is one of the oldest anticonvulsant medications. It is a barbiturate, and in alcohol withdrawal it does two things at once. It boosts the activity of GABA, the brain's main calming signal, and it dampens glutamate, the main excitatory signal. Both are thrown off balance when someone who drinks heavily suddenly stops. ACEP's critical care newsletter describes this dual action and ties it to prevention of seizures and delirium tremens.
That dual action is the main point of difference. A 2025 analysis in JAMA Network Open frames it this way: phenobarbital works on both dominant features of withdrawal physiology, whereas benzodiazepines enhance GABA signaling only.
The second feature is duration. Phenobarbital has a half-life of roughly 80 to 120 hours, which means a single well-calculated dose keeps working for days. In practice that smooths out the peaks and valleys that short-acting drugs can produce, and it can keep a patient stable through the window when seizures are most likely.
Why withdrawal needs this kind of attention
Alcohol withdrawal ranges from shaky hands and a racing heart to seizures and delirium tremens, a state of confusion, agitation and hallucinations with unstable vital signs. You cannot predict at the start which course yours will take. If you want a clearer picture of how symptoms tend to progress, our alcohol withdrawal timeline lays out the hours and the red flags, and our guide to alcohol withdrawal seizures covers risk and timing.
Phenobarbital vs. Ativan and other benzodiazepines
This is the question most readers arrive with, and the honest answer has two layers.
First, benzodiazepines such as lorazepam (Ativan), diazepam (Valium) and chlordiazepoxide (Librium) are still considered first-line therapy. The 2024 dosing review says so directly and describes phenobarbital monotherapy as an alternative for people at risk of serious or complicated withdrawal, or already in severe withdrawal, when extensive monitoring is available.
Second, there are reasons clinicians reach for phenobarbital in the hardest cases. The same review notes a longer half-life, the GABA and glutamate mechanism, and possible reductions in total hospital and ICU length of stay and in respiratory complications such as intubation. A 2023 retrospective cohort study found fewer respiratory complications, including intubation and oxygen requirement, among patients treated with phenobarbital than among those on standard benzodiazepine protocols.
| Feature | Phenobarbital | Benzodiazepines (e.g., Ativan) |
|---|---|---|
| Mechanism | Boosts GABA, dampens glutamate | Boosts GABA |
| Half-life | About 80 to 120 hours | Varies by drug, generally shorter for lorazepam |
| Typical role | Alternative for severe or high-risk withdrawal with close monitoring | First-line therapy |
| Main risk | Over-sedation, respiratory depression at high or rapid doses | Over-sedation, dependence, can fail in severe cases |
| Setting | Inpatient or highly supervised | Inpatient and, for mild cases, sometimes outpatient under medical direction |
A fair reading of the evidence includes its limits. ACEP notes that adequately powered randomized controlled trials comparing benzodiazepines with barbiturates for alcohol withdrawal are still lacking, and much of the favorable data comes from retrospective studies. Hospitals differ in how they use it, and the choice is a clinical judgment, not a rule.
How clinicians dose and monitor it
You do not need to memorize dosing, but it helps to know why this is supervised medicine. Protocols are weight-based and carefully capped.
- The University of Alabama at Birmingham's ICU guideline uses 5 to 10 mg/kg of ideal body weight as an IV piggyback, with a maximum cumulative dose of 10 to 15 mg/kg. It calls for at least two hours of monitoring, continuous oximetry and capnography, and blood pressure checks every 15 to 30 minutes.
- A community hospital that built phenobarbital into its order sets used intravenous loading doses of 10 or 15 mg/kg.
- Dosing is generally equivalent one to one when switching between intravenous, intramuscular and oral routes.
The pattern is consistent: a calculated dose based on body weight, a ceiling, and close observation of breathing and blood pressure. That is not something to improvise at home.
Risks, side effects and interactions
Phenobarbital has a narrow therapeutic window. The gap between a dose that calms withdrawal and a dose that over-sedates is smaller than many people expect. The ASAM clinical practice guideline recommends parenteral phenobarbital only in highly supervised settings such as an ICU or CCU because of the risk of respiratory depression and over-sedation, and stresses that clinicians need experience with the drug.
The product labeling adds specifics:
- Risks include respiratory depression, somnolence and dependence.
- Contraindications include sensitivity to barbiturates, porphyria, marked liver impairment and severe respiratory distress.
- Alcohol and other central nervous system depressants can add to the sedative effect.
- Giving it intravenously too quickly can cause severe respiratory depression, apnea, laryngospasm or a drop in blood pressure.
Practical takeaways for safe use: tell your care team about every medication, supplement and substance you use, including opioids, sleep aids, anti-anxiety drugs and cannabis. Disclose liver disease and any history of seizures or delirium tremens. Do not drink while on it. And never take leftover phenobarbital or any sedative that was prescribed to someone else.
Who may be considered for phenobarbital
Per ASAM, phenobarbital is typically considered in inpatient or highly supervised settings as an alternative when benzodiazepines are contraindicated or when withdrawal is severe. Factors that push a clinician toward it, or away from it, generally include:
- Severity so far. Rising agitation, a high withdrawal score, or symptoms that are not controlled by standard medication.
- History. Past seizures or delirium tremens during earlier withdrawals.
- Other conditions. Liver function, lung disease, and other sedating medications.
- Monitoring available. Whether staff can track breathing and blood pressure continuously.
- Co-occurring conditions. Anxiety, depression, trauma or other mental health needs that shape the whole plan.
If you are trying to judge how serious your own situation is, the struggles of alcohol use disorder are worth understanding before withdrawal starts, because the pattern and length of drinking influence how rough stopping can be.
When withdrawal is an emergency
Seizures, hallucinations, severe confusion or signs of delirium tremens need emergency care, and so do breathing trouble or extreme drowsiness after any sedating medication. According to ASAM, that means calling 911 or going to a hospital emergency department. For treatment referrals, the SAMHSA National Helpline is available at 1-800-662-HELP (4357), as ASAM's guideline notes for people in the United States.
If you are still drinking and thinking about stopping, speak to a medical professional first. Our page on preparing for withdrawal explains what to ask, and our article on alcohol detox at home explains why the 48 to 72 hour window is the one to respect. Anxiety often rebounds hard in this period too, and we cover that in anxiety and alcohol and in coping with withdrawal and anxiety.
Other medicines come up in conversations about withdrawal as well. Our overview of gabapentin for alcohol withdrawal explains what it can and cannot do. Which medication is right is always a prescriber's call, based on your history and exam.
Perspective
Here is how we think about it at Connected Recovery. Medication choice matters, but the setting around the medication matters just as much. Withdrawal is not a single drug decision. It is hours of observation, reassessment, hydration, sleep, nutrition and reassurance, and it is the people watching closely who catch a change early.
We built our program around that idea. With a deliberately small 12-bed capacity, each person is known by the staff on shift, not lost in a crowd. Medical supervision runs around the clock, so a change in breathing, blood pressure or mood is noticed and acted on, whatever the hour.
We also believe detox is the start, not the finish. Many people who struggle with alcohol are also living with anxiety, depression or trauma. Treating only the withdrawal and sending someone home leaves that untouched. An integrated plan, from detox through residential care to aftercare, gives recovery a better foundation.
If you or someone you love is facing withdrawal, our advice is simple: do not do it alone and do not guess at medication. Get evaluated by a medical team that can tailor the plan to you.
Jim
Medically supervised detox in Van Nuys
If you are weighing where to go through withdrawal, our medical detox program offers 24/7 medical supervision in a boutique, 12-bed residential setting in Van Nuys, Los Angeles. Treatment plans are individualized, and care for co-occurring mental health conditions is part of how we work through our dual diagnosis treatment.
After detox, people can continue into residential treatment, with medication-assisted treatment where it is appropriate and aftercare planning to support the months that follow. Admissions are confidential. To talk through your situation, reach us through Connected Recovery.
How to prepare for a supervised withdrawal
Whether you are entering a hospital or a detox facility, a little preparation helps the clinical team help you.
- Write down your drinking pattern. How much, how often, and when you last drank. Be honest: clinicians use this to anticipate severity, not to judge.
- List every medication and substance. Include prescriptions, over-the-counter products, supplements and other drugs. Interactions with sedatives are a core safety issue.
- Share your history. Prior withdrawals, seizures, hallucinations, liver problems, and mental health diagnoses.
- Do not stop abruptly by yourself. If you drink daily, ask a medical professional how to start safely.
- Bring a support person. A family member who can speak to your history and handle logistics is valuable when you are unwell.
- Ask about the plan after detox. Withdrawal treatment without a next step leaves a gap. Ask about residential care, therapy and aftercare before you start.
What families should know
Family members often face the decision before the person drinking does. A few points can help. Withdrawal symptoms can start within hours of the last drink and can worsen over the first days, so waiting to see how bad it gets is a risky plan. Someone who has had seizures or confusion before should not withdraw without medical care. And if the person is already seizing, hallucinating, or cannot be woken normally, call 911 instead of driving them yourself.
It also helps to know what to ask a facility. Does it provide round-the-clock medical supervision? How does it assess withdrawal severity and who decides on medication? What happens if someone needs a hospital? How does it treat co-occurring anxiety or depression? Does it help plan for discharge? A good program will answer these plainly.
FAQ
Is phenobarbital better than Ativan for alcohol withdrawal?
Not across the board. Benzodiazepines like Ativan are still first-line, and phenobarbital is considered an alternative for severe or high-risk cases when close monitoring is available. Some studies suggest fewer respiratory complications with phenobarbital, but large randomized trials are lacking. Your clinician chooses based on your history and risk.
Can I take phenobarbital at home to get through withdrawal?
No. Phenobarbital has a narrow therapeutic window, and over-sedation and slowed breathing are real dangers, especially if alcohol or other sedatives are in your system. ASAM limits parenteral use to highly supervised settings. If you are planning to stop drinking, talk to a medical professional first.
How long does phenobarbital stay in the body?
Its half-life is roughly 80 to 120 hours, so effects can last for days. That long duration is part of why it can keep patients stable through withdrawal, and part of why dosing has to be careful.
What are the warning signs that withdrawal is an emergency?
Seizures, hallucinations, severe confusion, or signs of delirium tremens need emergency care, as do breathing problems or extreme drowsiness after sedating medication. Call 911 or go to an emergency department. For treatment referrals, SAMHSA's National Helpline is 1-800-662-HELP (4357).
Sources
- Phenobarbital for Alcohol Withdrawal, ACEP Critical Care
- Phenobarbital Dosing for the Treatment of Alcohol Withdrawal, PMC
- Hospital-Wide Implementation, Clinical Outcomes, and Safety, JAMA Network Open
- Phenobarbital versus benzodiazepines in alcohol withdrawal, PMC
- Intravenous Phenobarbital Guideline for Alcohol Withdrawal, UAB
- The ASAM Clinical Practice Guideline on Alcohol Withdrawal Management
- Phenobarbital Sodium Injection package insert, Drugs.com
- Phenobarbital Sodium Injection FDA label, NDC 42494-442